Status | Study |
Recruiting |
Study Name: CREATE: Cross-tumoral Phase 2 With Crizotinib Condition: Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma Locally Advanced and/or Me Date: 2012-01-24 Interventions: Drug: Crizotinib (PF-02341066) For patients of 15yo and older, Capsules of 200 and 250 mg Daily dose of |
Completed |
Study Name: Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Macrobeads in Subjects With Castration-Resistant Prostate Cancer Resistant to Taxanes (Docetaxel, Cabazitaxel) and Evidence of Disease Progression on Androgen-axis Inhibition and/or Immunotherapy in the Form of Sipuleucel-T Condition: Prostate Cancer Date: 2010-08-01 Interventions: Biological: Cancer Macrobead placement in abdominal cavity 8 macrobeads per kilogram |
Recruiting |
Study Name: Open-Label Phase 2 Efficacy Trial of Cancer Macrobeads in Patients With Treatment-Resistant Pancreatic or Colorectal Cancer Condition: Pancreatic Cancer Colorectal Cancer Date: 2010-01-20 Interventions: Biological: Cancer macrobead placement in abdominal cavity 8 macrobeads per kilogram |
Completed |
Study Name: A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC) Condition: Carcinoma, Renal Cell Date: 2008-07-29 Interventions: Drug: foretinib (formerly GSK1363089 or XL880) treatment with oral foretinib on one of 2 dosing regimens |
Terminated |
Study Name: Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer Condition: Kidney Cancer Date: 2008-01-22 Interventions: Biological: bevacizumab 15 mg/kg over 90 minutes every 3 weeks |
Terminated |
Study Name: Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer Condition: Kidney Cancer Date: 2007-10-05 Interventions: Drug: sunitinib malate |
Completed |
Study Name: Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer Condition: Kidney Cancer Date: 2007-04-11 Interventions: Drug: sunitinib malate |
Completed |
Study Name: TroVax Renal Immunotherapy Survival Trial Condition: Clear Cell Renal Carcinoma Date: 2006-11-08 Interventions: Biological: Trovax 1ml IM injection 2-8 weeks apart. |
Completed |
Study Name: Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors Condition: Childhood Renal Cell Carcinoma Clear Cell Renal Cell Carcinoma Date: 2006-06-08 Interventions: Drug: Doxorubicin Hydrochloride |
Completed |
Study Name: Mouse Cancer Cell-containing Macrobeads in the Treatment of Human Cancer Condition: Intraabdominal Cancers (Various Types) Date: 2006-01-26 Interventions: Biological: Cancer Macrobead placement in abdominal cavity 8 macrobeads per kg |